Printed from the IBC Life Sciences Web site on May 16, 2012 11:54 PM ET.
Page location: http://www.ibclifesciences.com/BDPWeek/overview.xml
February 25 - March 01, 2013 · Hyatt Regency Huntington Beach Resort and Spa · Huntington Beach, CA
Sign up to receive email updates or new information on the 2013 event as it becomes available.
2011 Conference Materials - Online Documentation
Speaker presentation slides, biographies and related materials received to date are available on a secure, password protected website set up for our attendees.
If you pre-registered for the conferences you were sent an email on February 22, 2012 from "Dostie, Keri" with the subject line "Your Conference Materials and Updates for Next Week". This email contains the link and password to the presentation materials website. If you did not receive this email, please contact customer service at custserv@ibcusa.com.
Please Note: New or updated presentations collected onsite at the conference will be added (upon speakers' approval) to the site after the conference. Also, we do not always receive permission from all speakers to post their slides, so you will only be able to access slides from speakers who gave us permission to post them.
Agenda Updates/ Final Conference Agendas:
For a copy of the 2011 final agendas, you can, download a copy of the onsite event guide.
» Visit the "Biopharmaceutical Development & Production" events page to communicate with attendees all year round. See who has posted about their experiences at the event, or feel free to start some discussions of your own.
"Good topics, good people, discussions on the point!"
- J. Friedle, Managing Director, Atoll GmbH
"A fluid representation of the changing landscape of our industry, allowing for invaluable networking opportunities and topical discussions."
- B.D. Monroe, Process Science Fellow, Life Technologies
Thank you to our attendees, sponsors, and media partners who supported IBC's Biopharmaceutical Development & Production Week 2012.
With a full week of nine co-located conferences, the industry's top scientists, engineers and executives all joined together to find the latest technical and scientific advances in their field of study. This unique event offered attendees the opportunity to learn strategies from each of the cross-discipline areas, that they could apply in their own operations.
"These well-organized conferences cover the key topics and areas of interest across the biotech industry. They provide an excellent forum to exchange ideas and create networking contacts." - W.D. Taylor, Director, Business Development, Pfenex
For 2013, this week long event will be comprised of the following 9 conferences:
![]() |
Antibody Development & Production Combining Technical and Scientific Innovations with Industry Collaboration to Overcome Bioprocessing Challenges February 27 - March 1, 2013 www.IBCLifeSciences.com/antibodyprod |
![]() |
Process and Product Validation Moving Towards a LifeCycle and Risk-based Approach for Continuous Validation February 25-27, 2013 www.IBCLifeSciences.com/process |
![]() |
Technology Transfer for Biopharmaceuticals Maximizing Facility Throughput, Accelerating Timelines and Ensuring Partnership Success in Technology Transfer February 25-27, 2013 www.IBCLifeSciences.com/transfer |
![]() |
Outsourcing Manufacturing of Biopharmaceuticals Risk Mitigating and Productivity Improvement through Successful Partnering & Co-Development with CMOs February 25-27, 2013 www.IBCLifeSciences.com/outsourcing |
![]() |
Recombinant Protein & Complex Biologic Development & Production Approaches to Overcome the Unique Technical and Scientific Challenges of Developing Novel Molecules February 27 - March 1, 2013 www.IBCLifeSciences.com/recombinant |
![]() |
Analytical Technologies for Biotherapeutic Development Implementing Novel Analytical Approaches and Technologies from Early to Late Stage Development to Enable Project Progression February 27 - March 1, 2013 www.IBCLifeSciences.com/Analytical |
![]() |
Biopharmaceutical Raw Materials throughout the Product Lifecycle Strategies to Identify, Test, Control and Mitigate Risk of Raw Material Variability in Upstream/Downstream Development and Clinical/Commercial Manufacturing February 25-27, 2013 www.IBCLifeSciences.com/RawMaterials |
![]() |
Viral Safety for Biologicals Strategies, Technologies and Regulatory Perspectives for Detection, Prevention and Remediation in Upstream, Downstream and Manufacturing Operations February 25-27, 2013 www.IBCLifeSciences.com/ViralSafety |
![]() |
Biobetters & Biosimilars: Technologies and Development Strategies Turning Potential into Realistic Opportunities and Commercial Viability February 27 - March 1, 2013 www.IBCLifeSciences.com/biobetters |
"I greatly enjoyed the quality of the case studies that were presented. The speakers were very open to sharing ideas and lessons learned from real-world projects." - M. Pujols, Manufacturing Director, MedImmune, LLC
